Lung & Bronchus
C33-C34WHO Vol. 5
Thorax (Respiratory & Mediastinum)
★ 8.0Nature Reviews Clinical Oncology
2026-08-26
Global cancer statistics 2024: translating epidemiological trends into priorities for healthcare systems
A review in Nature Reviews Clinical Oncology discusses the global cancer burden using GLOBOCAN 2024 estimates: in 2024, 20.6 million people across 186 countries were diagnosed with cancer and 9.8 million died of it. Lung cancer remains the most common — 2.6 million new cases (12.8%) and 1.9 million …
Read the full story →★ 8.0NEJM — Current Issue
2026-05-29
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
First-line sunvozertinib prolonged progression-free survival compared with chemotherapy, but overall survival remains unknown — the data were immature (39% maturity). In the phase 3 WU-KONG28 trial (n=324), median progression-free survival was 10.3 versus 7.5 months (HR 0.65; 95% CI 0.50-0.85; P<0.0…
Read the full story →